Bu çalışmadaki amacımız 0-18 yaş arası çocuklarda Sitomegalovirüs’e karşı oluşmuş IgM ve IgG tipi antikorların varlığını retrospektif olarak incelemek ve seroprevalans oranlarını belirlemektir. Bu çalışmada 2018-2019 yıllarında Erzurum merkezde aile hekimlerince farklı nedenlerle muayene edilen ve CMV IgM-IgG serolojisi araştırılan kişilere ait sonuçların retrospektif olarak değerlendirilmesi yapıldı. Hastalardan alınan kan serumları Halk Sağlığı Seroloji Laboratuvarında ELISA yöntemi kullanılarak Architect İ2000 cihazında firmanın çalışma prosedürüne uygun olarak çalışıldı. Kit üretici firmanın tavsiyeleri doğrultusunda test sonuçları, CMV IgM için; 0.99 index pozitif, CMV IgG için; 5.99 AU/ml pozitif olarak kabul edildi. Araştırma grubunda anti-CMV IgG seropozitifliği %95,7 (491/513), anti-CMV IgM seropozitifliği %2.4 (13/546) bulundu. CMV IgG ve IgM pozitifliği sırasıyla, kız çocuklarında %96.7 ve %2.4, erkek çocuklarda % 92.6 ve %2.4 idi. Kız çocukları arasında anti-CMV IgG pozitiflik oranları daha yüksek idi. Çalışmamızda 0-3, 4-6, 7-9, 10-12, 13-15 ve 16-18 yaş gruplarında anti-CMV IgG seropozitifliği sırasıyla %94.7; %69.6; %100; %97.5; %88.2 ve %99.3 idi. Anti-CMV IgM seropozitifliği ise aynı yaş gruplarında %10.5; 0; 0; %2.4; %4.4 ve %1.7 idi. Çalışma grubumuzdaki çocuklarda CMV seropozitiflik oranları yüksekti. Bu durum bölgemizdeki çocukların erken yaşlarda (konjenital veya edinsel) CMV etkenine maruz kaldığını göstermektedir.
1 January 2022 in TURKISH JOURNAL OF MEDICAL SCIENCES
Background/aim: There is limited data on COVID-19 disease in children with kidney disease. We aimed to investigate the characteristics and prognosis of COVID-19 in pediatric nephrology patients in Turkey. Materials and methods: This was a national, multicenter, retrospective cohort study based on an online survey evaluating the data between 11th March 2020 and 11th March 2021 as an initial step of a detailed pediatric nephrology COVID-19 registry. Results: Two hundred and three patients (89 girls and 114 boys) were diagnosed with COVID-19. One-third of these patients (36.9%) were between 10-15 years old. Half of the patients were on kidney replacement therapy: kidney transplant (KTx) recipients (n = 56, 27.5%), patients receiving chronic hemodialysis (n = 33, 16.3%) and those on peritoneal dialysis (PD) (n = 18, 8.9%). Fifty-four (26.6%) children were asymptomatic. Eighty-two (40.3%) patients were hospitalized and 23 (28%) needed intensive care unit admission. Fiftyfive percent of the patients were not treated, while the remaining was given favipiravir (20.7%), steroid (16.3%), and hydroxychloroquine (11.3%). Acute kidney injury developed in 19.5% of hospitalized patients. Five (2.4%) had MIS-C. Eighty-three percent of the patients were discharged without any apparent sequelae, while 7 (3.4%) died. One hundred and eight health care staff were infected during the study period. Conclusion: COVID-19 was most commonly seen in patients who underwent KTx and received HD. The combined immunosuppressive therapy and frequent exposure to the hospital setting may increase these patients' susceptibility. Staff infections before vaccination era were alarming, various precautions should be taken for infection control, particularly optimal vaccination coverage.
Aim: In this study, it was aimed to examine the serum endocan levels in patients with rheumatic aortic regurgitation and to investigate whether it has a value in differentiating it from aortic regurgitation due to bicuspid aortic valve.Methods: Blood samples were collected from patients with rheumatic aortic regurgitation (Group 1), incidentally diagnosed patients with borderline or definite rheumatic aortic regurgitation (Group 2), children with bicuspid aortic valve accompanied by aortic regurgitation (Group 3) and healthy children (Group 4) of similar age.Results: There were 12 children in Group 1, 13 in Group 2, 25 in Group 3, and 25 in Group 4. Groups were similar in terms of age (p = 0.291). There was no statistically significant difference between median serum endocan levels of Group 1 and Group 2 (p = 0.624), and Group 3 and Group 4 (p = 0.443). Despite that, the median serum endocan levels of Group 1 and Group 2 were significantly higher than that of both Group 3 and Group 4 (p = 0.000 for all).Conclusions: Our results indicate that serum endocan level can be used to differentiate rheumatic aortic regurgitation from non-rheumatic aortic regurgitation. It is thought that the prognostic role of this marker should be confirmed in long-term, prospective studies with larger samples.
Nörokutan hastalıklar, merkezi sinir sistemi ve cilt bulgularının yanı sıra sıklıkla böbrek tutulumu gösteren multisistemik bozukluklardır; özellikle Nörofibromatozis tip 1, Tüberoskleroz kompleksi ve Von Hippel-Lindau hastalığı gibi tablolar önemli nefrolojik riskler taşır. Bu hastalıkların yönetimi, hipertansiyon ve vasküler lezyonların erken tespiti ile çok disiplinli bir takip yaklaşımı gerektirir. Tedavi süreçlerinde cerrahi yerine genellikle organ koruyucu girişimler ve farmakolojik yaklaşımlar ön plana çıkmaktadır. Neurocutaneous diseases are multisystemic disorders that frequently present with renal involvement alongside central nervous system and skin manifestations; conditions such as Neurofibromatosis type 1, Tuberous sclerosis complex, and Von Hippel-Lindau disease pose significant nephrological risks. Management of these conditions requires a multidisciplinary approach focused on the early detection of hypertension and vascular lesions. Treatment processes generally prioritize organ-sparing interventions and pharmacological approaches over surgery.